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RESEARCH ARTICLE

ELAC2/RNaseZ-linked cardiac hypertrophy in
Drosophila melanogaster

ABSTRACT
A severe form of infantile cardiomyopathy (CM) has been linked to
mutations in ELAC2, a highly conserved human gene. It encodes Zinc
phosphodiesterase ELAC protein 2 (ELAC2), which plays an
essential role in the production of mature tRNAs. To establish a
causal connection between ELAC2 variants and CM, here we used
the Drosophila melanogaster model organism, which carries the
ELAC2 homolog RNaseZ. Even though RNaseZ and ELAC2 have
diverged in some of their biological functions, our study demonstrates
the use of the fly model to study the mechanism of ELAC2-related
pathology. We established transgenic lines harboring RNaseZ with
CM-linked mutations in the background of endogenous RNaseZ
knockout. Importantly, we found that the phenotype of these flies is
consistent with the pathological features in human patients.
Specifically, expression of CM-linked variants in flies caused heart
hypertrophy and led to reduction in cardiac contractility associated
with a rare form of CM. This study provides first experimental
evidence for the pathogenicity of CM-causing mutations in the ELAC2
protein, and the foundation to improve our understanding and
diagnosis of this rare infantile disease.
This article has an associated First Person interview with the first
author of the paper.
KEY WORDS: Drosophila, Cardiomyopathy, ELAC2, RNase Z, OCM

INTRODUCTION

Cardiomyopathy (CM) is a group of diseases that weaken the
heart muscle and compromise its ability to pump blood.
Cardiomyopathies can lead to major health complications, such as
arrhythmia, heart failure and sudden cardiac death. Two main types
of CM are recognized based on heart morphology and function:
hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy
(DCM). The most prevalent form is HCM, with one in 500 people
being affected. It is defined by the thickening of the left ventricular
heart wall, cardiomyocyte hypertrophy, and reduced heart volume at
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systole and diastole. HCM is the most common cause of sudden
cardiac death among adolescent children (McKenna et al., 1981).
DCM, however, is estimated to occur in one out of 2500 people.
DCM is described as the dilation of either the left or both ventricles
together with systolic dysfunction (Taylor et al., 2006). In rare cases,
HCM can progress into dilated stage (D-HCM), which combines
both heart wall thickening and heart cavity dilation. D-HCM has a
very poor prognosis and often ends with heart failure, whereas
DCM can be managed (Hamada et al., 2010). Despite good
comprehension of CM pathophysiology, the molecular mechanisms
leading to this condition are not completely understood, nor have
the effective prevention strategies been developed yet.
Cardiomyopathies affect people of all ages. The number of CM
cases in infants is lower than in adults but the mortality rate among
newborns is significantly higher, especially if the symptoms develop
before the age of 1 (Maron et al., 1995). Unlike the adult form, which
is primarily caused by particular health conditions, viral infections
and behavior (Guzzo-Merello et al., 2014; Kearney et al., 2001;
Messerli et al., 2017), infantile CM is due to inherited mutations; it is
clinically and etiologically heterogeneous. At least 80 genes have
been linked to infantile cardiomyopathies (Dellefave and McNally,
2010; Roma-Rodriguez and Fernades, 2014); they have been grouped
based on the frequency of mutations associated with infantile CM
(Hershberger et al., 2013; Keren et al., 2008; McNally et al., 2015).
Most often affected are genes that encode proteins involved in
cardiomyocyte contraction through their association with sarcomeres,
e.g. cardiac myosins and troponins (Hershberger et al., 2013;
Kamisago et al., 2000). The second group of genes that are
frequently impaired in CM patients encode cytoskeleton proteins in
myocytes, e.g. vinculin (Olson et al., 2002) and cypher (LDB3)
(Vatta et al., 2003). Finally, there is a large third group of genes,
whose estimated contribution to the total number of CM cases is
relatively small. Genes of this group encode a variety of different
proteins, and include ion channel, cell junction, spliceosome and
nuclear envelope proteins to name a few (Hershberger et al., 2013).
A recent discovery added another gene to the list of those
associated with infantile CM. Mutations in the gene encoding the
tRNA processing endonuclease (ELAC2, hereafter referred to as
RNaseZ) are linked to the early onset of CM symptoms (Haack et al.,
2013; Shinwari et al., 2017). Patients diagnosed with cardiomyopathy
due to mutations in ELAC2 have a median life expectancy of
4 months (Shinwari et al., 2017). ELAC2-related heart impairment
has allelic and phenotypic heterogeneity. Together, 25 ELAC2 alleles
have been associated with cardiac pathology: two frameshift, five
splice and 18 missense mutations (Saoura et al., 2019). In addition to
CM, patients carrying ELAC2 mutations suffer from a variety of
abnormalities including mitochondrial respiratory chain deficiency,
retardation of the intrauterine growth, delay in the psychomotor
development, encephalopathy and muscular hypotonia (Akawi et al.,
2016; Haack et al., 2013; Kim et al., 2017; Shinwari et al., 2017).
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Most patients with ELAC2 mutations were diagnosed with HCM;
although, there were few cases described as DCM or D-HCM (Haack
et al., 2013; Shinwari et al., 2017; Saoura et al., 2019). Although
advanced genetic studies that involve exome sequencing and pedigree
analysis found a strong association between ELAC2 variants and CM
(Haack et al., 2013), experimental evidence providing proof of the
disease-causing effect of ELAC2 mutations is still missing. To
experimentally validate the predicted damaging effect of ELAC2
variants a well-established model organism can be used.
The ELAC2 protein has homologs in all eukaryotes, and its
function has been studied extensively by using the Drosophila
melanogaster homolog RNaseZ (Dubrovsky et al., 2004). ELAC2/
RNaseZ endoribonuclease is essential for tRNA maturation. Initially,
a tRNA is produced with extensions at both ends (Phizicky and
Hopper, 2010). For the tRNA molecule to become functional
endonucleolytic cuts have to be made by RNaseP and RNaseZ at the
5′ and 3′ end, respectively (Hartmann et al., 2009). RNaseZ belongs
to the metallo-β-lactamase (MBL) family of proteins, all of which
feature a common structure, the MBL domain (Kostelecky et al.,
2006). This domain is composed of five motifs (I to V). Motifs II, III,
IV and V comprise seven highly conserved histidine and/or aspartate
residues involved in zinc ion binding and coordination within
the catalytic center (Aravind, 1999; Vogel et al., 2002; Späth et al.,
2005). Motif I, while being part of the active site of the enzyme, is also
involved in substrate recognition and binding. RNaseZ has two
additional functional motifs – a PxKxRN loop and an exosite both
contributing to the tRNA substrate recognition (Kostelecky et al.,
2006; Zareen et al., 2006). The tRNA 3′-end processing endonuclease
exists in two forms – the short form (RNaseZS), found in all three
domains of life, and the long form (RNaseZL) found only in
eukaryotes (Vogel et al., 2005). RNaseZL is thought to have
evolved from the RNaseZS gene duplication (Tavtigian et al., 2001;
Vogel et al., 2005). Some eukaryotes (S. cerevisiae, C. elegans,
D. melanogaster) have only a long version of RNaseZ, while
others, e.g. H. sapiens, have both forms of the enzyme. In humans,
RNaseZS is encoded by ELAC1 and RNaseZL by ELAC2 (Takahashi
et al., 2008). As a consequence of tandem duplication and fusion,
RNaseZL is built of two homologous halves, each carrying the
MBL domain. However only the C-terminal domain is catalytically
active. Motifs I-V of the N-terminal domain are termed pseudo
motifs and do not participate in catalysis (Fig. 1) (Zhao et al.,
2010). Interestingly, the exosite is present only in the N-terminal

half; the C-terminal half of RNaseZL appears to have lost this motif
(Ma et al., 2017). Even though the biochemical activity and the crystal
structure of functional domains of RNaseZL protein have been
identified (Ma et al., 2017), the understanding of how mutations in the
gene encoding this protein lead to cardiac hypertrophy is still missing.
Given the homology of ELAC2 and RNaseZ, we decided to turn
to a Drosophila model to study the effect of mutant RNaseZ forms
on fly heart and body physiology. The fly heart has a tubular
structure and is often referred to as the dorsal vessel owing to its
spatial position under the dorsal body wall. It is formed during
embryogenesis by 104 contractile cardiomyocytes that are arranged
in two opposing rows that form a luminal space in between them.
The contractile elements of cardiomyocytes are myofibrils, which
are discrete bundles of actomyosin filaments, uniformly distributed
around the vessel. The dorsal vessel is divided into the heart, a
contractile chamber and the aorta, i.e. an outflow tract (Curtis et al.,
1999). During embryonic and larval stages, the heart is positioned in
the posterior abdominal segments A5-A8 and the aorta extends from
the heart towards the anterior end into thoracic segment T3. During
metamorphosis, parts of the larval heart undergo programmed cell
death, reducing the number of cardiomyocytes to 84 (Sellin et al.,
2006). At the same time, the anterior part of the aorta enlarges to
form the contractile chamber of an adult heart in abdominal
segments A1-A4 (Sellin et al., 2006). Unlike in vertebrates, the
heart function in Drosophila can be severely compromised without
causing immediate death (Zhu et al., 2017a,b). However, the genetic
network controlling cardiac development as well as certain features
of heart physiology and function are well conserved from flies
to mammals (Ocorr et al., 2007). A variety of resources available
for Drosophila research allow the investigation of cellular and
molecular mechanisms that contribute to cardiomyopathies (Wolf
and Rockman, 2011; Neely et al., 2010), which makes Drosophila a
great model to study human cardiac disorders.
Here, we tested whether two missense mutations that were
previously identified in human patients (Haack et al., 2013) cause
cardiac pathology in Drosophila. We created fly models harboring
mutated versions of the RNaseZ gene that are linked to CM-causing
mutations of ELAC2 and found that these flies did recapitulate main
symptoms, including increased thickness of the heart wall, dilated
heart lumen and decreased cardiac contractility. These findings
provide experimental evidence of a direct connection between
ELAC2 variants and cardiomyopathy.
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Fig. 1. Comparison of human ELAC2 and Drosophila RNaseZ proteins. Two colored bars represent protein structures of ELAC2 and RNaseZ with
conserved MBL domains and functional motifs being designated (drawn not to scale). Localization and conservation of amino acid residues known to be
affected by CM-linked mutations – F154L, T520I – as well as the positions of mutations – F155L, T494I – introduced into RNaseZ amino acid sequence are
shown. MTS, mitochondrial targeting sequence; NLS, nuclear localization signal.
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RESULTS
Functional homology of human ELAC2 and Drosophila
RNaseZ proteins

Generation of flies carrying CM-linked mutations

Fig. 2. ELAC2 rescues the earlylethality phenotype of RNaseZ KO
homozygotes. (A) Mouth hook
morphology of homozygote KO (Z24)
and rescued (Z24;hs-ELAC2 and
Z24;hs-Z+) larvae shows that both
transgenes (hs-ELAC2 and hs-Z+)
help Z24 mutants to survive early
lethality and reach 3rd instar.
(B) Appearance of the Z24 knockout
(left panel) at its terminal larval
stage compared with rescued larvae
Z24;hs-ELAC2 (middle panel) and
Z24;hs-Z+ (right panel). (C) Body
mass of homozygote KO (Z24) and
rescued (Z24;hs-ELAC2 and Z24;
hs-Z+) animals at their terminal
larval stages (n=20). (D) Body
length of homozygote KO (Z24) and
rescued (Z24;hs-ELAC2 and Z24;
hs-Z+) animals at their terminal
larval stages (n=20). (E) Pupariation
rate of homozygote KO (Z24)
animals rescued with either
hs-ELAC2 or hs-Z+ (n=240). Z24
larvae do not pupariate as they die
at 2nd instar. ***P<0.001 (ANOVA).
Error bars indicate the mean±s.e.m.
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The homology between the human ELAC2 and Drosophila RNaseZ
proteins was established based on amino acid sequence similarity
(Fig. 1) (Dubrovsky et al., 2004; Zhao et al., 2010). Moreover, both
proteins have the same biochemical activity in vitro and in vivo
(Takaku et al., 2003; Xie et al., 2011). Here, we decided to evaluate
the degree of biological function conservation of ELAC2 and
RNaseZ through the rescue experiment. We have previously
generated and characterized the Z24 null lethal allele of RNaseZ
(Xie et al., 2013). Z24 homozygotes die during 2nd instar on day 3
after egg deposition (AED). We assessed whether the early larval
lethality of Z24 animals can be rescued by a heat shock (hs)-driven
ELAC2 transgene (hs-ELAC2). As a positive control, we used the
wild-type RNaseZ transgene under the hs promoter (hs-Z+) (Xie et al.,
2013). Experimental and control larvae were subjected to hs treatment
every 24 h starting at day 1 AED. We found that Z24;hs-ELAC2
transgenic flies, indeed, escaped early lethality of the Z24 null mutant.
On day 5 AED they reached 3rd instar (Fig. 2A); however, there was a
clear difference in body size and weight between rescued individuals
of two genotypes. Larvae expressing hs-ELAC2 showed, on average,
only 77% of the length and 40% of the mass of age-matched control
larvae expressing hs-Z+ (Fig. 2B-D). hs-ELAC2 larvae exhibited
reduced development rate as they pupariated 4 days later than
expected. The number of larvae reaching pupariation (59 out of 240)
was reduced by 53% compared to control larvae (Fig. 2E). Animals
that pupariated died soon after, the rest of larvae survived up to
25 days but eventually died without any sign of pupariation. These
results showed that human ELAC2 introduced into an RNaseZ
knockout background significantly improves larval viability.
However, the pupariation rate of rescued larvae was only 50%
compared with that of control larvae, and adult survival is zero. Thus,
although the two proteins are known to be true functional homologs,
ELAC2 cannot complement RNaseZ knockout in flies.

Because ELAC2 failed to rescue Z24 KO, we decided to use the
Drosophila homolog RNaseZ to model CM-related mutations in
flies. Alignment of ELAC2 and RNaseZ showed that, out of 13
ELAC2 missense mutations associated with CM, seven affect amino
acid residues that are highly conserved and located within the same
motifs that constitute homologous functional domains of human
and Drosophila protein. Two of these mutations, F154L and T520I
are well characterized in terms of their clinical manifestation (Haack
et al., 2013).
Previously, we have described the gZ+-V5 construct containing a
fragment of genomic DNA that encompasses the coding sequence of
V5-tagged RNaseZ together with its endogenous regulatory
sequences (Xie et al., 2013). By using this construct and sitedirected mutagenesis, we introduced CM-linked missense mutations
F155L (nucleotide 463C→T) and T494I (nucleotide 1539C→T)
into the RNaseZ ORF to produce gZHCM1 and gZHCM2 alleles
(Fig. 1). Both mutations were confirmed by DNA sequencing.
Western blot analysis showed that transgenic flies carrying
corresponding constructs express similar amounts of wild-type and
mutant versions of RNaseZ protein (Fig. S2). To study the impact of
CM-linked mutations on flies, we introduced gZHCM1 and gZHCM2
transgenes into the RNaseZ null background (Z24). Thus, transgenes
became the sole source of RNaseZ protein. In all experiments we
used flies that carry either one (Z24;gZHCM/+) or two (Z24;gZHCM/
gZHCM) copies of the transgene – hereafter designated as 1xgZHCM
and 2xgZHCM, respectively. Control flies carry one copy of the
transgene encoding wild-type protein, 1xgZ+ (Z24;gZ+/+).
RNaseZ is an essential gene, which implies that gZHCM mutations
could have an effect on fly development and lifespan. We found that
both transgenic fly lines displayed a minor delay regarding their
progression through the life cycle, as they pupariated and eclosed
12-24 h later compared to control flies. Interestingly, although the
viability of mutant flies at eclosion was not affected, longevity of
adults was significantly reduced. The median adult lifespan was

∼41 days for 2xgZHCM1, 22 days for 2xgZHCM2, 9 days for
1xgZHCM1 and 4 days for 1xgZHCM2, compared to 61 days for
1xgZ+ control flies (P>0.0001; Fig. 3).
From day of eclosion, the gZHCM-expressing transgenic flies did
not appear as active as age-matched control flies. To evaluate the
effect of HCM mutations on fly fitness, we measured the locomotor
activity of 2-day-old transgenics by using the negative geotaxis
climbing assay (Gargano et al., 2005; Piazza et al., 2009). All flies
carrying mutant RNaseZ transgenes exhibited a reduction of the
climbing index by 47% for 2xgZHCM1, 67% for 2xgZHCM2, 78%
for 1xgZHCM1 and 88% for 1xgZHCM2 compared to age-matched
control (Fig. 4). In both longevity and fitness assays, flies that
carried one copy of the gZHCM transgene showed a stronger
phenotype than flies that carried two copies; therefore, only the
former flies were used in subsequent experiments.
gZHCM1 and gZHCM2 mutations lead to heart hypertrophy in
Drosophila

The majority of patients carrying CM-linked ELAC2 variants
display dramatic thickening of the left ventricular heart wall soon
after birth (Haack et al., 2013; Shinwari et al., 2017). To study the
effect of HCM mutations on the morphology of the fly heart, we
conducted a histological analysis of hearts obtained from larvae and
young adults. We measured the thickness of the heart wall using 5μm sections of the dorsal vessel sliced in transverse orientation. In
general, the heart wall thickness was irregular throughout the
circumference of the heart tube (Fig. 5A,B). To account for that,
dorsal, ventral and lateral heart wall measurements were collected,
and averaged from three consecutive sections. We found that the
heart wall thickness of larvae was increased by 54% in 1xgZHCM1
and 39% in 1xgZHCM2 compared to control larvae (Fig. 5C). The
effect of mutations on heart wall thickness was more pronounced in
adult flies, with an increase of 123% in 1xgZHCM1 and 111% in
1xgZHCM2 (Fig. 5D). These results indicate that HCM mutations
lead to heart wall hypertrophy in flies.

Fig. 3. gZHCM mutants show a decrease in longevity. Adult fly longevity
was assessed by daily counting live flies over time. Shown are survival rates
for Z24 KO flies carrying one or two copies of the gZHCM transgene, i.e.
1xgZHCM1 (Z24;gZHCM1/+), 1xgZHCM2 (Z24;gZHCM2/+), 2xgZHCM1 (Z24;gZHCM1/
gZHCM1) and 2xgZHCM2 (Z24;gZHCM2/gZHCM2). Control flies carry one copy of
the wild-type transgene 1xgZ+ (Z24;gZ+/+). n>300 for each genotype.
P<0.0001 (Mantel–Cox test). Error bars indicate the mean±s.e.m.
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Fig. 4. gZHCM mutants show a decrease in locomotor response.
Negative geotaxis expressed as the climbing index is shown for control flies
1xgZ+ (Z24;gZ+/+) and mutants – 1xgZHCM1 (Z24;gZHCM1/+), 1xgZHCM2 (Z24;
gZHCM2/+), 2xgZHCM1 (Z24;gZHCM1/gZHCM1) and 2xgZHCM2 (Z24;gZHCM2/
gZHCM2), with n>80 for each genotype. ***P<0.001 (one-tailed t-test). Error
bars indicate the mean±s.e.m.

gZHCM1 and gZHCM2 mutations compromise heart function in
Drosophila

Patients with hypertrophic hearts display abnormal ventrical volume
and reduced cardiac contractility. Therefore, we investigated
whether HCM mutations affect heart activity in larvae and adult
flies. We used a high-resolution optical coherence microscopy
(OCM) system to image hearts for functional studies. OCM is a noninvasive imaging technology that enables visualization of organs in
vivo (Alex et al., 2005; Men et al., 2016; Wolf et al., 2006). Light
penetrates cuticle and is reflected from the structures underneath,
yielding images similar to those obtained when using ultrasound.
Representative images of larval and adult heart obtained by OCM
are shown in Fig. 6. End-diastolic area (EDA) or end-systolic area
(ESA) of the heart lumen when the heart was fully relaxed or
contracted, respectively, were measured in transverse orientation.
We found that EDA was increased by 39% in 1xgZHCM1 and 47%
in 1xgZHCM2 larvae (Fig. 6C). ESA was also increased by 46% in
1xgZHCM1 and 78% in 1xgZHCM2 compared to age-matched control
larvae (Fig. 6C; Movies 1-3).
In adults, hearts of gZHCM flies showed a diastolic and systolic
increase of the lumen area by 111% for 1xgZHCM1 and 107% for
1xgZHCM2 (diastole), and by 176% for 1xgZHCM1 and 206% for
1xgZHCM2 (systole) (Fig. 6D; Movies 4-6).
To summarize, the hearts of gZHCM flies are dilated at diastole
and do not contract efficiently at systole. From these parameters, we
calculated fractional shortening (FS) as a measure of heart-tube
contractility. In larvae, FS was either the same as in controls (see
1xgZHCM1 in Fig. 6C) or slightly reduced by 6% in 1xgZHCM2
(Fig. 6C). Adult hearts showed a stronger reduction of heart-tube
contractility, i.e. a decrease by 17% in 1xgZHCM1 and by 23% in
1xgZHCM2 (Fig. 6D). These data demonstrate that the cardiac
function was compromised in flies carrying the HCM-linked
sequence variant of RNaseZ.
gZHCM1 and gZHCM2 mutations lead to an increase in nuclei
number and ploidy in Drosophila hearts

Heart wall thickness could increase due to cardiomyocyte growth
(hypertrophy), proliferation (hyperplasia) or both. Yet, neither of
these HCM features were looked at in human patients carrying
ELAC2 variants. The Drosophila model is very much suitable to
study both myocyte hypertrophy and hyperplasia due to the
simplicity of the fly heart.
4
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Fig. 5. gZHCM mutants show markedly increased
heart wall thickness. (A,B) Histological sections in
transverse orientations showing heart wall thicknesses
of control 1xgZ+ (Z24;gZ+/+) and mutant animals
1xgZHCM1 (Z24;gZHCM1/+) and 1xgZHCM2 (Z24;gZHCM2/+).
In (A), A6/A7 abdominal segments of the heart of 3rd
instar larvae. In (B), A1/A2 abdominal segments of the
heart of young adults (6-9 days after eclosion). Arrows
point at the heart wall. (C,D) Quantification of heart wall
thicknesses measured from serial transverse histological
sections of larvae 1xgZ+ (n=32), 1xgZHCM1 (n=13) and
1xgZHCM2 (n=22) (C), and adult flies 1xgZ+ (n=15),
1xgZHCM1 (n=8) and 1x gZHCM2 (n=7) (D). ***P<0.001
and ****P<0.0001 (one-way ANOVA followed by
Dunnett’s multiple comparison’s test). Error bars indicate
the mean±s.e.m.

gZHCM1 and gZHCM2 mutations lead to increased deposition
of ECM components in Drosophila hearts

Drosophila heart is embedded in extracellular matrix (ECM),
the components of which are secreted by pericardial cells,
cardiomyocytes and adipocytes (Rotstein and Paululat, 2016;
Vaughan et al., 2018). In mammals, myocardial fibrosis
(increased amounts of ECM proteins) is a hallmark of HCM and
correlates with the degree of hypertrophy, impaired ventricular
performance and diastolic dysfunction (Ho et al., 2010;
Teekakirikul et al., 2012). In Drosophila, deposition of extra
amounts of collagen and collagen-like proteins is also tied to
decreased cardiac performance and hypertrophy (Na et al., 2013;
Vaughan et al., 2018). Therefore, we explored whether fibrosis is
part of the phenotype associated with gZHCM mutations.
We specifically focused on accumulation of pericardin (PRC), an
insect collagen IV-like ECM protein found exclusively around the
dorsal vessel. Immunostaining of dissected hearts from 2-day-old
mutant flies for PRC showed a quantifiable increase in the PRC
immunofluorescence signal compared to that in hearts from agematched control flies (Fig. 8A,B). Western blot analysis of total
protein from isolated hearts confirmed increased levels of PRC in
gZHCM mutants compared to those of control hearts (Fig. 8C,D).
Thus, it appears that fibrosis also attributes to a hypertrophic heart in
gZHCM flies.
DISCUSSION
Partial functional homology of ELAC2 and RNaseZ

Generation of functional tRNA 3′-ends is essential for all
organisms. Eukaryotes universally employ highly conserved
endoribonucleases for this purpose. Both human ELAC2 and fly
RNaseZ proteins possess the same biochemical activity as they
5
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To identify and track cardiomyocytes, we engineered a transgenic
Drosophila strain that expresses GFP in cardiomyocytes, i.e. for
a high level of cardiac-specific expression, we cloned GFP
ORF under promoter featuring four tandem repeats of the tinCΔ4
cardiac enhancer from the Drosophila tinman gene (Lo and Frasch,
2001). The resulting transgene 4xtinCΔ4-GFPNLS allowed clear
visualization of the nuclei of all cells within the heart, including
myocytes, the heart valve and ostia cells, at every developmental
stage. To quantify cardiac nuclei under normal and hypertrophic
conditions, we introduced the 4xtinCΔ4-GFPNLS transgene into
RNaseZ wild-type (Z24;gZ+/4xtinCΔ4-GFPNLS) and mutant (Z24;
gZHCM/4xtinCΔ4-GFPNLS) genetic backgrounds. First, we confirmed
that wild-type control flies consistently displayed eight nuclei per
segment (n=19) (Fig. 7A). Amazingly, we found more nuclei per heart
segment in mutants – ≤13 for 1xgZHCM1 and ≤10 for 1xgZHCM2
(Fig. 7A). These extra cardiomyocyte nuclei were found in 55% of
1xgZHCM1 (n=21) and 38% of 1xgZHCM2 (n=18) flies examined.
In general, cell size is proportional to the amount of nuclear DNA
(Edgar and Orr-Weaver, 2001). Many post-mitotic cells, e.g.
mammalian cardiac myocytes, grow by endoreplication, a process
of multiple rounds of genomic DNA replication without cytokinesis
(Ahuja et al., 2007). Thus, to evaluate potential cardiomyocyte
hypertrophy in gZHCM flies, we measured the ploidy of heart cells.
Consistent with previous studies (Yu et al., 2013), our DAPI staining
showed varied ploidy of wild-type Drosophila cardiomyocytes,
ranging from four to 36, with a mean C value of 13 (Fig. 7B).
Importantly, mutant cardiomyocytes showed increased ploidy – the
mean C value for 1xgZHCM1 and 1xgZHCM2 was 17, P<0.001
(Fig. 6B). Our data clearly demonstrate that both RNaseZ variants
yielded hypertrophic hearts built of cardiomyocytes with increased
ploidy and, probably, increased size.
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cleave off the tRNA 3′-end in vitro and in vivo (Dubrovsky et al.,
2004; Takaku et al., 2003). We, therefore, investigated the extent of
biological conservation of function of human and Drosophila
enzymes in vivo. We produced flies carrying the hs-ELAC2
transgene in an RNaseZ null background. Rescue experiments
revealed that the human homolog was only partially substituting for
its Drosophila counterpart. Human ELAC2 complements the
function of Drosophila RNaseZ at larval stages, leading to larval
growth, molting and even pupariation of some of the animals.
However, most of the rescued animals stall their developmental
progress during fully grown 3rd instar stage and die 20 days later.
Only a small number (59 out of 240) of rescued larvae pupariated at
approximately day 9 AED; however, their development did not
progress much further and they died as early pupae. Thus, it appears
that, even though human and Drosophila lineages separated more
than 700 million years ago (Hedges et al., 2006), two proteins
retained some functional homology. Nonetheless, the inability of
ELAC2 to rescue RNaseZ KO flies into adulthood, clearly reflects
the divergence of their biological functions.
Apparently, RNaseZ has some functions not carried out by
ELAC2. This might be due to the fact that humans have two forms
of this protein – the long ELAC2 (RNaseZL) and the short ELAC1
(RNaseZS) version – whereas only a long version exists in
Drosophila. ELAC2 has been shown to colocalize with nuclei and
mitochondria, whereas ELAC1 resides in the cytosol (Takahashi
et al., 2008). Until recently, only little was known about ELAC1
function but a new study has shown that ELAC1 has a role in tRNA

recycling, which takes place in cytosol and, thus, cannot be
completed by ELAC2 (Yip et al., 2020). It appears that in flies,
RNAseZ carries out functions that are in humans performed by both
ELAC1 and ELAC2. In Drosophila cells, RNaseZ has been
detected in all three compartments – nuclei, mitochondria and
cytosol, making it possible for the Drosophila protein to have some
activities similar to ELAC1. In addition, RNaseZ might have some
other – yet unknown – roles in flies. Consequently, replacing
RNaseZ with ELAC2 may not restore all of the essential functions
of RNaseZ in flies, which is a likely explanation for the incomplete
rescue. It would be interesting to see whether supplying both human
ELAC1 and ELAC2 can rescue an RNaseZ KO in flies.
Thus, we conclude that, even though ELAC2 and RNaseZ appear
to be highly conserved, their functions have diverged.
F154L and T520I ELAC2 alleles are causally connected to CM

In humans, multiple mutations of ELAC2 have been associated with
the early onset of cardiac hypertrophy and decompensation (Haack
et al., 2013; Shinwari et al., 2017), although the causal connection
between mutant ELAC2 forms and CM has not been explicitly
established. In our study, we used RNaseZ – a Drosophila homolog
of ELAC2 – to generate fly models carrying human CM-associated
alleles. Our histological analysis established that flies with mutant
RNaseZ had hypertrophic heart wall (Fig. 5). Moreover, using OCM
technology we found that the size of the heart lumen, as assessed at
both diastole and systole, was increased (Fig. 6C,D). Finally,
judging by FS (Fig. 6C,D) the contractility of the heart was reduced.
6
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Fig. 6. gZHCM mutants exhibit dilation of the heart. (A) OCM images of diastole and systole in A6/A7 heart segment of control 1xgZ+ (Z24;gZ+/+) and
mutant larvae – 1xgZHCM1 (Z24;gZHCM1/+) and 1xgZHCM2 (Z24;gZHCM2/+). Scale bar: 100 µm. (B) Functional analysis of larval hearts. End-diastolic area
(EDA), end-systolic area (ESA) and fractional shortening (FS) are shown for 1xgZ+ (n=19), 1xgZHCM1 (n=20) and 1xgZHCM2 (n=22) larvae. (C) OCM images
of diastole and systole in A1/A2 heart segments of control 1xgZ+ (Z24;gZ+/+) and mutant – 1xgZHCM1 (Z24;gZHCM1/+), 1xgZHCM2 (Z24;gZHCM2/+) young adult
flies. All genotypes were studied 6-9 days after eclosion. (D) Functional analysis of adult fly hearts. EDA, ESA and FS are shown for 1xgZ+ (n=15), 1xgZHCM1
(n=13) and 1xgZHCM2 (n=13) flies. N.S., no statistical significance; *P<0.05, **P<0.025, ***P<0.01 (one-way ANOVA followed by Dunnett’s multiple
comparisons test). Error bars indicate the mean±s.e.m.
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Notably, the early onset of the CM phenotype in Drosophila was
consistent with the early appearance of CM symptoms in patients
carrying ELAC2 variants. Thus, our data provided direct
experimental evidence that the F154L and T520I mutations of
ELAC2 are the primary cause of this heart pathology.
Interestingly, we found that characteristic traits of heart
impairment are already apparent during the larval phase of
development but they became much stronger and fully
pronounced in adult gZHCM flies. Drosophila heart develops early
in embryogenesis; during larval stages and metamorphosis it
undergoes further growth and differentiation but without cell
proliferation. We did not expect any heart phenotype in embryos, as
the RNaseZ gene has a maternal effect, i.e. its mRNA is produced
and deposited into the oocyte during oogenesis (Xie et al., 2013). As
soon as maternal RNaseZ stores are depleted, cardiomyocytes start
to experience the damaging effect of RNaseZ variants. Given that
RNaseZ processes both mitochondrial and nuclear pre-tRNA
transcripts, its activity is required throughout animal development

(Dubrovsky et al., 2004; Xie et al., 2013). This explains why adults
display the strongest phenotype – cardiomyocytes accumulate the
damage produced by RNaseZ mutant variants from larva-to-pupato-adult.
It appears that the hearts of gZHCM flies combine features of both
hypertrophic and dilated cardiomyopathy, reminiscent of the dilated
stage of hypertrophic cardiomyopathy (D-HCM) reported for some
patients with ELAC2 mutations. Whereas dilated and hypertrophic
cardiomyopathies are traditionally classified as two distinct
pathologies, it has been suggested that, in some cases, they
represent consecutive stages in the progression of the same disease
(Bingisser et al., 1994; Harris et al., 2006; Hamada et al., 2010).
Having a fly model with the features of a rare form of cardiac
disease, offers an opportunity to study the underlying mechanisms.
Some studies that describe CM cases associated with ELAC2,
have proposed incomplete processing of mitochondrial transcripts
as the cause of organelle malfunction that, in turn, leads to heart
hypertrophy (Haack et al., 2013; Saoura et al., 2019). The fly model
7
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Fig. 7. gZHCM mutants show an increase in cardiomyocyte
nuclei number and ploidy. (A) Fluorescence imaging of
nuclear GFP in hearts of control 1xgZ+ (Z24;gZ+/4xtinCΔ4GFPNLS) and mutant young adults – 1xgZHCM1 (Z24;gZHCM1/
4xtinCΔ4-GFPNLS) and 1xgZHCM2 (Z24;gZHCM2/4xtinCΔ4GFPNLS). Flies of all genotypes were studied 1-2 days after
eclosion. The A2-A4 abdominal segments are shown; white
vertical bars mark the segment boundaries. Scale bar:
100 µm. (B) Plotted is the distribution of cardiomyocyte nuclei
with different ploidy (C value) from 1xgZ+ (n=400 nuclei),
1xgZHCM1 (n=534 nuclei), and 1xgZHCM2 (n=429 nuclei) as
black, gray and white bars, respectively. For each ploidy
range, the nuclei number is provided as the percentage of
nuclei of total number being studied for each genotype. The
mean ploidy C value is shown for each group in parenthesis.
***P<0.01 (one-way ANOVA followed by Dunnett’s multiple
comparison’s test).
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established by us and described in this study will be extremely
useful in testing this hypothesis.
Increased ploidy of cardiomyocytes and accumulation of
ECM components are aspects of the cardiac hypertrophy
phenotype in adult flies

In general, heart wall enlargement could result from either an
increase in cardiomyocyte number (hyperplasia) and/or size
(hypertrophy), accumulation of ECM components (fibrosis), or a
combination of these processes. Hypertrophy and fibrosis are wellknown hallmark features of HCM in humans and flies (McKenna
et al., 1981; Marian and Braunwald, 2017; Na et al., 2013);
however, hyperplasia has not been detected and/or studied, except
for the few cases in the mouse HCM model (Becker et al., 2011;
Farrell et al., 2017). As to HCM patients carrying ELAC2 variants,
none has been tested for hyperplasia, hypertrophy or fibrosis.
The heart tube of adult Drosophila comprises 84 cells, all of
which originate during embryogenesis from cardiac progenitor cells

(Rotstein and Paululat, 2016). While proceeding through the larval
stages, the size of the heart tube increases, although this
enlargement does not involve myocyte proliferation but, rather,
cell growth by endoreplication (also known as endocycling) – a
specialized cell cycle during which cells increase their ploidy and
size without karyokinesis or cytokinesis (Edgar and Orr-Weaver,
2001; Edgar and Nijhout, 2004; Zielke et al., 2013). Thus, the heart
of the adult fly is entirely postmitotic and composed of polyploid
mononucleated cardiomyocytes (Yu et al., 2013; this study). By
using RNA interference (RNAi) and genetic knockout, we have
previously shown that Drosophila RNaseZ is required for cell
growth via endoreplication but that its absence does not directly
affect DNA replication (Xie et al., 2011, 2013). In this current study,
we tested two hypomorphic alleles – gZHCM1 and gZHCM2 – and
found that both cause an increase in cardiomyocyte ploidy by ∼32%
on average (Fig. 7B). Moreover, our data showed that flies with
HCM-linked sequence variants of RNaseZ develop hearts with
more cardiomyocyte nuclei per segment than those in wild-type fly
8
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Fig. 8. gZHCM mutants show an increased deposition of pericardin. (A) Representative confocal images of hearts from control 1xgZ+ (Z24;gZ+/4xtinCΔ4GFPNLS) and mutant young adults – 1xgZHCM1 (Z24;gZHCM1/4xtinCΔ4-GFPNLS) and 1xgZHCM2 (Z24;gZHCM2/4xtinCΔ4-GFPNLS) – stained against pericardin
(PRC). All fluorescent images were taken by using the same exposure parameters. Fluorescent intensities were measured within the region of interest
selected over A1-A4 segments of the heart tube (boxed areas). Flies of all genotypes were studied 1-2 days after eclosion. (B) Average pixel intensity of PRC
immunostaining, n=4. (C) Western blot of total proteins from isolated hearts of control (1xgZ+) and mutant flies (1xgZHCM1 and 1xgZHCM2) stained against
PRC. Silver staining was used as a loading control. (D) Quantification of PRC levels (arbitrary unit) relative to loading control, normalized to the control
genotype. Data are the average of four independent experiments. N.S., not statistically significant; *P<0.05, **P<0.025, one-way ANOVA followed by
Dunnett’s multiple comparison’s test. Error bars, mean±s.e.m.
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(Fig. 7A). This phenomenon illustrates that cardiomyocytes of
gZHCM mutant flies not only replicate DNA but, after the replication
step, may enter mitosis, ending with either cytokinesis (resulting in
hyperplasia) or karyokinesis (resulting in polyploid binucleated
cells).
It is not clear yet what prompts cardiomyocytes of flies that carry
gZHCM alleles to re-enter and go through additional rounds of
endocycling. Previously, we have shown that loss of mitochondrial
RNaseZ activity increases levels of intracellular reactive oxygen
species (ROS), resulting in genotoxic stress (Xie and Dubrovsky,
2015). A recent study proposed that postmitotic cells experiencing
oxidative stress and associated DNA damage may gain protection
by initiating endoreplication and developing polyploidy
(Nandakumar et al., 2020). Therefore, one potential pathway that
connects RNaseZ mutant alleles and heart hypertrophy could be
mediated by ROS, although further experiments are required to
confirm this suggestion.
Given that fibrosis is a well-documented characteristic of HCM,
we studied the ECM in gZHCM flies by looking at levels of PRC, a
prominent ECM protein deposited exclusively around the
Drosophila heart tube. Notably, flies carrying gZHCM1 and/or
gZHCM2 alleles displayed higher levels of PRC compared to control
flies (Fig. 8). Based on investigations published by others (Na et al.,
2013; Vaughan et al., 2018), PRC accumulation could be one of the
reasons of heart malfunction in gZHCM flies.
Overall, our current study not only provides the proof that directly
implicates ELAC2 sequence variants in HCM, but offers a
convenient model to study mechanisms and pathway leading to
heart pathology.

together form the catalytic center (Saoura et al., 2019). This
suggests that even subtle changes of motif I, such as loss of polarity
due to T520I substitution, potentially impairs the efficacy of
catalysis.
The gZHCM1 mutation is located in the N-terminal half of the
RNaseZ protein, between pseudo motifs II and III. Based on the
tertiary structure of ELAC2/RNaseZ, the site of gZHCM1 (F154L) is
positioned close to the interface between the N- and C-terminal
MBL domains, approaching the motif II region of the C-terminal
half (Saoura et al., 2019). It has been suggested that reducing the
size of the hydrophobic side chain, such as the case of F154L
substitution, affects the folding of the region, which is crucial for
binding metal ions and efficient catalysis (Saoura et al., 2019).
Although both mutations potentially affect catalytic activity of
ELAC2/RNaseZ, the gZHCM2 position is located within a highly
conserved region, implying that this missense mutation can bring
upon a stronger damage to the function of the enzyme than gZHCM1.
This explains a more-pronounced negative effect of this mutation
both in humans and in flies.

In addition to studying the structure and function of the heart, we
also examined our HCM fly model for other traits that could be
reflective of symptoms displayed by patients with cardiomyopathy.
We noticed that HCM flies experienced delayed development,
similar to intra-uterine growth retardation in humans. We also found
that RNaseZ knockout flies carrying gZHCM transgenes have a
dramatically shortened lifespan, which is reminiscent of the
decreased life expectancy of HCM patients (Akawi et al., 2016;
Haack et al., 2013; Kim et al., 2017; Shinwari et al., 2017). Lastly,
by using the negative geotaxis climbing assay, we observed that
ZHCM1 and ZHCM2 mutations decrease fly fitness levels. This feature
is consistent with muscle hypotonia and retarded psychomotor
development in human patients (Akawi et al., 2016; Haack et al.,
2013; Kim et al., 2017; Shinwari et al., 2017).
Overall, gZHCM flies exhibit multiple phenotypes that are similar
to symptoms in humans. In both organisms, HCM-linked mutations
affect heart morphology and function, fitness level, rate of
development and longevity.
Comparison of mutant RNaseZ transgenes

Based on our analysis of gZHCM1 and gZHCM2 alleles, the latter has a
stronger negative effect on all traits that were studied by us –
longevity, level fitness and heart function. Importantly, these
observations are consistent with those in humans. For example,
patients with the T520I allele (gZHCM2) live – at most – to the age of
6 months, whereas patients with the F154L variant (gZHCM1) may
live up to 13 months of age. This difference could be explained by
the fact that the T520I mutation affects a highly conserved residue in
motif I. The in silico analysis of the ELAC2/RNaseZ structure
shows that motif I interacts with motifs II-V, the latter of which

Fly stocks

Flies were maintained at 25°C on standard cornmeal-molasses-agar
medium. The RNaseZ knockout allele used in this study (Z24) as well
as the hs-RNZ-V5 (hs-Z+) and genRNZ-V5 (gZ+) constructs and
corresponding transgenic flies are described elsewhere (Xie et al., 2011,
2013).
DNA cloning and generation of transgenic fly strains

To generate the hs-ELAC2-V5 (hs-ELAC2) construct, the ELAC2 coding
sequence was joined at the C-terminal end with the V5-epitope sequence
and placed under the heat-inducible promoter in the pCaSpeR-hs vector.
Transgenic flies were generated by P element-mediated germline
transformation. Several homozygous viable transgenic lines carrying this
construct on the third chromosome were established. Transgene expression
was activated by heatshock (HS) treatment at 37°C for 1 h; full-size protein
synthesis was confirmed by western blot hybridization with the anti-V5
antibody (Fig. S1).
To introduce CM-linked mutations into RNaseZ we amplified fragments
of RNaseZ with the following pairs of primers: (5′-AATTGCCTCGGCCAAGGATC-3′ with 5′-CACCACGAGACGTCGCATTGAC-3′ and 5′CGACGTCTCGTGGTGCTAAAGAATCTC-3′ with 5′-AGCAGAATAAGTGGGTCTGCC-3′) for ZHCM1, (5′-AATTGCCTCGGCCAAGGATC3′ with 5′-GACCATAAATTCCTTCTCCACAATCC-3′ and 5′-GTGGAGAAGGAATTTATGGTCAAATTG-3′ with 5′-AGCAGAATAAGTGGGTCTGCC-3′) for ZHCM2 (letters in bold indicate introduced nucleotide
changes). We used NEBuilder HiFi DNA Assembly master mix (New
England BioLabs) to insert the amplified fragments into BamHI and AvrII
sites of the genRNZ-V5 construct (Xie et al., 2011), yielding the
genRNZHCM1-V5 (gZHCM1) and genRNZHCM2-V5 (gZHCM2) constructs.
E. coli transformants were picked, and successful cloning was confirmed by
restriction digestion and sequencing. To establish transgenic lines, we used
phiC31-mediated site-specific integration to insert the transgenes into the
AttP site on third chromosome at 68A4 (Groth et al., 2004).
To create a strong heart-specific promoter, the 303 bp tinCΔ4 enhancer
element of the tinman gene was amplified with the following pairs of
primers (5′-ctatagggcgaattgggtacctctagaCATGAACAGCTTTCGATCG-3′
with 5′-AaggaatccctAAGCGGAAATTGTGGTGTTTTC-3′ and 5′-atttccgcttAGGGATTCCTGGGGAGGG-3′ with 5′-aaaagctggagctccaccgcggcctaggtGGAGGCAGGGAAACATTTTAC-3′), where capital letters indicate
the gene-specific part in each primer (Lo and Frasch, 2001). To generate the
4xtinCΔ4 fragment we used the NEBuilder HiFi DNA Assembly master mix
to sequentially introduce four tandem insertions of tinCΔ4 into SacII and
KpnI sites of the pBlueScriptII plasmid. After confirming the integrity of
the 4xtinCΔ4 fragment by DNA sequencing, it was cut out, purified and
ligated into XbaI and SacII sites of pH-Stinger vector (DGRC), yielding the
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4xtinCΔ4-GFPNLS construct. Transgenic flies were generated by P elementmediated germline transformation. Several homozygous viable transgenic
lines carrying this construct on 3rd chromosome were established.
Transgene expression was confirmed by GFP accumulation in
cardiomyocyte nuclei.

orientation at 5 µm thickness; sliced sections were placed on slides for
subsequent haematoxylin and eosin (H&E) staining.
To ensure heart wall measurements were consistently taken at the
transition of the A1-to-A2 segment in adult flies, we used the following
approach: i) we identified sections sliced through the anterior thoracic end;
ii) we removed the next 500 µm of tissue, which brought us into abdomen,
∼50 µm from the posterior end of the thorax; iii) we collected three
consecutive 5-µm thick sections for analysis. For larvae, heart wall thickness
was analyzed at 450-500 µm from the larval posterior end, which
corresponds to the A6/A7 segments.
Sections were rehydrated and H&E stained (Sigma). All histological
samples were analyzed under a Zeiss Axio Imager M1 microscope,
brightfield images were captured with an AxioCam MRc camera. Wall
thickness was calculated as the average of three measurements from each
section in three consecutive sections of the heart.

For ELAC2 rescue experiments we used offspring of the Z24/CyO,GFP;hsELAC2 line. In the same experiment, offspring of Z24/CyO,GFP served as a
negative control and offspring of Z24/CyO,GFP;hs-Z+ as positive control.
Larvae homozygous for the Z24 allele were selected by the absence of the
GFP marker. All animals were subjected to HS treatment for 1 h, every 24 h
from day 1 after egg deposition (AED).
Western blot analysis

For adult fly analysis, protein extracts were made by homogenizing five
whole animals in Laemmli sample buffer. For heart analysis, ten hearts were
dissected from 1- to 2-day-old adult female flies, homogenized in 25 µl
ECM extraction buffer (1 mM EDTA, 1,5% Triton X-100 and 2 M urea) and
then supplemented with 25 µl 2× Laemmli buffer. All samples were boiled
at 99°C for 3 min. Aliquots were separated on a SDS-polyacrylamide gel
and subjected to either western blotting or silver staining. For PRC analysis,
blotting buffer was supplemented with 2 M urea. Blots were hybridized
overnight at 4°C with primary antibodies diluted in PBST supplemented
with 5% dry milk powder (w/v). Antibodies used were anti-V5 (Invitrogen,
1:10,000), anti-α-tubulin (Sigma, 1:5000) and anti-pericardin (PRC,
DSHB, 0.2 µg/ml). Silver staining was performed using SilverXpress
staining kit (Life Technologies) following the manufacturer’s protocol.
Visualization of blots was done using KwikQuant Digital Western Blot
Detection System (Kindle Biosciences). Band densities were quantified
using the KwikQuant imaging software.
Longevity assay

To measure the lifespan, flies of indicated genotypes were collected on the
day of eclosion and placed into same-sex cohorts of ten flies per vial. The
number of survivors in each vial was scored daily. The flies were placed in
fresh vials three times per week (Monday, Wednesday and Friday) during
the entire test. Statistical analysis was performed using Mantel–Cox test.
Negative geotaxis climbing assay

Locomotor activity of the flies was tested using the geotaxis assay described
elsewhere (Gargano et al., 2005; Piazza et al., 2009). Flies were collected on
the day of eclosion under brief CO2 anesthesia (1-2 min), sorted in groups of
ten (five males and five females) and allowed to recover at least 18 h at 25°C
prior to the assay. Next day, flies were transferred into vials marked by lines
forming four equally spaced quadrants. Each vial was gently tapped to bring
flies to the bottom of the vial and to initiate the negative geotaxis response.
Flies were allowed to climb up for 4 s before a photograph was taken to
record the position of each fly in the vial. Each fly was assigned a rating
based on the quadrant it reached; flies that did not climb and stayed at the
bottom were scored as zero. The weighted average of three consecutive
trials was calculated for each vial, representing the climbing index for that
vial.
Histological analysis

To ensure all animals are studied at the same developmental point, we
synchronized them by behavioral and morphological criteria as described
elsewhere (Xie et al., 2011). Procedure to fix and process larvae for
histological analysis is described elsewhere (Velentzas and Baehrecke,
2021). Briefly, 3rd instar larvae were fixed in FAAG solution (80% EtOH,
5% acetic acid, 4% formaldehyde, 1% glutaraldehyde) for 24 h at 4°C. The
procedure to fix and process adult flies was adapted from previously
published protocols (Kucherenko et al., 2010; Yu et al., 2010). Briefly, adult
flies (6-9-day-old females) were fixed in Carnoy’s fixative overnight at 4°C.
After fixation, both larval and adult samples were dehydrated using
increasing gradients of EtOH solution, washed with xylenes and then placed
into hot paraffin. Solidified paraffin blocks were sliced at transverse

OCM analysis of cardiac function

For optical coherence microscopy (OCM), white light from a
supercontinuum source (SC-400-4, Fianium Ltd., UK) with a central
wavelength of ∼800 nm and a bandwidth of ∼220 nm was used. We used a
45° rod mirror to generate an annular sample probe beam to obtain an
extended depth of focus. The axial and transverse resolutions provided by
the OCM system were 1.5 μm and 3.9 μm, respectively. The backscattered
light from the reference and sample arms was detected using a spectrometer
comprising a 600 lines/mm transmission grating (Wasatch Photonics,
Logan, UT, USA) and a 2048 pixel line-scan camera (AViiVA EM4, e2v
technologies plc, UK), operated at 20k A-scans/s. Sensitivity of the system
was determined to be ∼95 dB with a sample arm power of 5 mW. M-mode
images were acquired at a frame rate of 128 Hz.
To ensure consistency of the heart tube location chosen for OCM
imaging, we employed an approach proposed and published elsewhere
(Men et al., 2016). Briefly, all specimens were imaged first in the
longitudinal orientation to identify the cardiac chamber and to adjust the
position of an animal, so that the widest area of the heart is in the focal plane
of the imaging beam in transverse orientation. Then, animals were imaged in
the transverse orientation to center the heart chamber.
Larval hearts were studied in A6/A7 segments. We measured enddiastolic areas (EDAs) and end-systolic areas (ESAs) of 30 consecutive
best-visible heartbeats per larva, using ImageJ (National Institutes of
Health, USA). Fractional shortening (FS) was calculated as (EDA−ESA)/
EDA×100%.
Adult hearts were studied at the transition of A1-to-A2 segment (∼50 µm
from the posterior end of the thorax), where the heart chamber is at its widest
and best visible. Usually, adult heart contractions display some variability
over time. To account for that, we collected EDA and ESA measurements
from the heart beats spaced at 3-s intervals throughout the 30 s of time-lapse
OCM images, giving us ten impartially selected heart beats from each
recording.
Heart immunostaining analysis

Adult females were collected on day 2 after eclosion, and hearts were
dissected but kept on the cuticle as previously described (Vogler and Ocorr,
2009). Briefly, the head and thorax were removed, and the abdomen was
placed in the Artificial Drosophila Hemolymph (ADH) buffer (5 mM HEPES
pH 7.1, 108 mM NaCl, 5 mM KCl, 2 mM CaCl2, 8 mM MgCl2, 1 mM
NaH2PO4, 4 mM NaHCO3, 10 mM sucrose, and 5 mM trehalose). The
abdomen was then cut open and internal organs were removed. ADH buffer
that contained 10 mM EGTA was added for 1 min to relax the cardiac muscle.
Next, samples were fixed in 4% formaldehyde in PBS for 20 min at room
temperature. To stain for pericardin (PRC), samples were hybridized
overnight at 4°C with monoclonal anti-PRC antibody (DSHB, 2 µg/ml)
diluted in PBS supplemented with 0.3% Triton X-100 (PBS/TX) buffer. After
three washes (10 min per wash) with PBS/TX, samples were hybridized for
1 h at room temperature with secondary goat anti-mouse antibody conjugated
to Alexa Fluor 647 (Jackson Immunoresearch, 1:400) diluted in PBS/TX.
Next, cuticles were washed three times (10 min per wash) in PBS/TX and
mounted on a glass slide using Vectashield antifade medium (Vector
Laboratories) and squashed by the coverslip for 10 s.
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Nuclei of cardiomyocyte were identified by the presence of GFP. The
stained heart preparations were visualized with a Leica TSP5 laser scanning
confocal microscope.
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Cardiomyocyte ploidy analysis

Cardiomyocyte ploidy was determined by adapting methods described
elsewhere (Xie et al., 2013; Yu et al., 2013). Adult Drosophila were
collected on day 2 after eclosion, and hearts were dissected but kept on the
cuticle in ADH buffer (see above). Imaginal wing discs from wild-type 3rd
instar larvae were also dissected and used as a diploid reference for DNA
quantification. For all following steps hearts and wing discs were treated in
parallel. Tissues were fixed in 4% formaldehyde/PBS at room temperature
for 20 min, washed three times (10 min per wash) in PBS/TX and stained at
room temperature in the dark for 10 min with Hoechst 33342 (Molecular
Probes) diluted 1:1000 in PBS/TX. Next, samples were washed three times
(10 min per wash) in PBS/TX, hearts pulled off the cuticle and placed on a
glass slide together with wing discs, mounted with Vectashield antifade
medium and squashed by the coverslip for 10 s. The samples were then
analyzed by obtaining z-stacks of Hoechst-stained nuclei using Leica TSP5
laser scanning confocal microscope. Cardiomyocytes were identified by the
presence of GFP in their nuclei. The intensity of Hoechst staining for each
cardiomyocyte and wing disc nuclei was quantified using ImageJ. To assess
the ploidy, the staining intensity of the cardiomyocyte nuclei was
normalized to the intensity of wing disc nuclei in each independent
experiment. Ploidy was expressed as the C-value, where C=1 refers to the
amount of DNA within a haploid nucleus.
Statistical analysis

All graphs and statistical analyses were performed in Microsoft Excel and
GraphPad Prism9. Statistical data are presented as the mean±s.e.m. P values
for all the comparisons were determined by one-way ANOVA followed by
Dunnett’s multiple comparison’s test unless specified otherwise. The mean
difference was considered statistically significant at the 95% confidence
level. Results were considered as not significant at P>0.05, significant
*P<0.05, very significant **P<0.025 and extremely significant
***P<0.001. Figures were assembled with Adobe Photoshop (Adobe
Systems, San Jose, CA). Sequence alignment was performed with Clustal
Omega 2 (Madeira et al., 2019).
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